Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Odink

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
The Journal of Clinical Endocrinology and Metabolism|October 7, 2016
ACAN Gene Mutations in Short Children Born SGA and Response to Growth Hormone TreatmentManouk van der Steen, Rolph Pfundt, Stephan J W H Maas, et al.
American Journal of Medical Genetics|January 9, 2001
Growth until puberty after in utero exposure to coumarinsD Van Driel, J Wesseling, F R Rosendaal, et al.
European Journal of Pediatrics|February 1, 1990
Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonistW Oostdijk, R Hümmelink, R J Odink, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational ageMarije van Dijk, Paul Mulder, Mieke Houdijk, et al.
European Journal of Pediatrics|May 1, 1987
The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious pubertyS L Drop, R J Odink, C Rouwé, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1985
Dietary intake, nutritional status and well-being of cancer patients: a prospective studyP F Bruning, R J Egger, A C Gooskens, et al.
European Journal of Endocrinology|January 30, 2010
High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult heightS A van Gool, G A Kamp, R J Odink, et al.
Journal of Medical Genetics|December 4, 2009
Phenotype-genotype correlation in a familial IGF1R microdeletion caseD C M Veenma, H J Eussen, L C P Govaerts, et al.
Archives of Disease in Childhood|October 15, 2017
Long-term follow-up after bilateral percutaneous epiphysiodesis around the knee to reduce excessive predicted final heightWesley J Goedegebuure, Frank Jonkers, Annemieke M Boot, et al.
Clinical Endocrinology|June 15, 2007
Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trialRuben H Willemsen, Nicolette J T Arends, Willie M Bakker-van Waarde, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
The Journal of Clinical Endocrinology and Metabolism|October 7, 2016
ACAN Gene Mutations in Short Children Born SGA and Response to Growth Hormone TreatmentManouk van der Steen, Rolph Pfundt, Stephan J W H Maas, et al.
American Journal of Medical Genetics|January 9, 2001
Growth until puberty after in utero exposure to coumarinsD Van Driel, J Wesseling, F R Rosendaal, et al.
European Journal of Pediatrics|February 1, 1990
Treatment of children with central precocious puberty by a slow-release gonadotropin-releasing hormone agonistW Oostdijk, R Hümmelink, R J Odink, et al.
The Journal of Clinical Endocrinology and Metabolism|February 9, 2006
High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational ageMarije van Dijk, Paul Mulder, Mieke Houdijk, et al.
European Journal of Pediatrics|May 1, 1987
The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious pubertyS L Drop, R J Odink, C Rouwé, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1985
Dietary intake, nutritional status and well-being of cancer patients: a prospective studyP F Bruning, R J Egger, A C Gooskens, et al.
European Journal of Endocrinology|January 30, 2010
High-dose GH treatment limited to the prepubertal period in young children with idiopathic short stature does not increase adult heightS A van Gool, G A Kamp, R J Odink, et al.
Journal of Medical Genetics|December 4, 2009
Phenotype-genotype correlation in a familial IGF1R microdeletion caseD C M Veenma, H J Eussen, L C P Govaerts, et al.
Archives of Disease in Childhood|October 15, 2017
Long-term follow-up after bilateral percutaneous epiphysiodesis around the knee to reduce excessive predicted final heightWesley J Goedegebuure, Frank Jonkers, Annemieke M Boot, et al.
Clinical Endocrinology|June 15, 2007
Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trialRuben H Willemsen, Nicolette J T Arends, Willie M Bakker-van Waarde, et al.
Pageof 11